[A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy]. - Concepedia

Concepedia

Publication | Closed Access

[A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy].

52

Citations

0

References

2006

Year

Jianan Wang, Xiaojie Xie, Hong He, Yong Sun, Jun Jiang, Rong‐Hua Luo, Youqi Fan, Liang Dong

Abstract

Percutaneous coronary autologous mesenchymal stem cells transplantation can attenuate the increase of plasma BNP, increase six-minute-walking capacity in patients with idiopathic dilated cardiomyopathy.